Autonomix Medical, Inc. (NASDAQ:AMIX) stock is trading higher on Monday, with a strong session volume of 6.11 million compared to the average volume of 22.87 thousand, as per data from Benzinga Pro. The nano-cap firm focused on developing technologies for the nervous system revealed preliminary results from the first five “lead-in” patients in the company’s ongoing proof-of-concept human trial evaluating the safety and effectiveness of delivering transvascular energy to ablate relevant problematic nerves and mitigate pain in patients with pancreatic cancer pain. Three patients were treated wit…